Fineline Cube

Follow:
14455 Articles
CompanyDrug

Zai Lab and argenx Report Positive Preliminary Results from Vyvgart Hytrulo CIDP Study

CompanyDeals

ObsEva SA Regains Full Rights to Nolasiban After Terminating Yuyuan Biological License Deal

CompanyDrug

Janssen’s Rybrevant Meets Primary Endpoint in Phase III NSCLC Study

CompanyDrug

Antengene Corp., Ltd Receives Hong Kong NDA Approval for Xpovio in Relapsed Multiple Myeloma

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-A1811 and Pyrotinib Combo Study

CompanyDeals

Shanghai Xinhengrui Medical Technology Secures Series A Funding for Heart Failure Device Development

CompanyDeals

Beyond Therapeutics Secures Tens of Millions in Pre-Series A Financing for Ophthalmology and Oncology Pipeline

CompanyDrug

Mabwell Bioscience Receives NMPA Approval to Launch 9MW2921 Clinical Study

CompanyDeals

Centre Medical Secures Tens of Millions in Series A Financing to Expand Globally

CompanyDrug

TransThera Sciences’ TT-00420 Receives Breakthrough Designation for Cholangiocarcinoma Treatment

CompanyDrug

Shenzhen Salubris Pharmaceuticals’ SAL0120 for IgA Nephropathy Accepted for NMPA Review

Policy / Regulatory

NHSA Unveils 2023 Flying Inspection Plan for Medical Insurance Fund Oversigh